Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 479

Results For "MED"

5370 News Found

L&T Technology Services (LTTS), collaborates with Intel for Chest rAI solution
Digitisation | October 01, 2021

L&T Technology Services (LTTS), collaborates with Intel for Chest rAI solution

The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance


Veeda Clinical Research files DRHP for Rs 831 crore IPO
News | October 01, 2021

Veeda Clinical Research files DRHP for Rs 831 crore IPO

The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders


NITI Aayog launches report on best practices in district hospitals
Public Health | October 01, 2021

NITI Aayog launches report on best practices in district hospitals

A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise


Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
Biotech | October 01, 2021

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA

The company plans to submit the IND application by the end of 2021


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


Merck to acquire Acceleron for US $ 11.5 billion
News | October 01, 2021

Merck to acquire Acceleron for US $ 11.5 billion

The acquisition complements and strengthens Merck’s cardiovascular pipeline


Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


Aurobindo Pharma’s subsidiary opens logistics centre in France
Supply Chain | September 30, 2021

Aurobindo Pharma’s subsidiary opens logistics centre in France

The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon


TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation
Digitisation | September 30, 2021

TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation

TCS to help Apoteket drive its digital transformation across sales channels and internal processes